Announce Date | 08/13/2025 |
EPS Normalized Actual | $1.08 (Beat by $1.34) |
EPS GAAP Actual | $1.08 (Beat by $1.34) |
Revenue Actual | $0.023708B |
Revenue Surprise | Beat by $23.708M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.05 |
EPS GAAP Estimate | $-0.05 |
Revenue Estimate | $0.0137B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 0.5 | 18.74 | 0.46869 | 0.53131 | 0 |
Dec 2027 | 0.49 | 19.12 | 0.44652 | 0.53348 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.87 | 0.92 | 0.023708B | 43.13% | 10.01M |
FQ1 2025 (Mar 2025) | -0.52 | -0.46 | 0.012924B | 29.45% | 0.42M |
FQ4 2024 (Dec 2024) | 0 | 0.035 | 0.017095B | 17.46% | 3.2M |
FQ3 2024 (Sep 2024) | -1.1 | -1.045 | 0.013663B | 23.63% | 1.16M |
FQ2 2024 (Jun 2024) | -1.34 | -2.68259 | 0.013483B | 34.04% | -4.3M |
FQ1 2024 (Mar 2024) | -0.17 | -0.17 | 0.009118B | -181.91% | 9.12M |
FQ4 2023 (Dec 2023) | 0.0789 | 0.0789 | 0.014111B | 100% | 14.11M |
FQ3 2023 (Sep 2023) | -0.2 | -0.2 | 0.010435B | 100% | 10.44M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.05
Consensus Revenue Estimates
0.0137B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0 | -- | 0 | 0 | 0 |
FQ3 2026 (Sep 2026) | 0 | -- | 0 | 0 | 0 |
FQ2 2026 (Jun 2026) | 0 | -INF | 0 | 0 | 0 |
FQ1 2026 (Mar 2026) | 0 | INF | 0 | 0 | 0 |
FQ4 2025 (Oct 2025) | -0.02 | -- | -0.0205098 | -0.0194902 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.02B | -- | 0.02B | 0.02B | 0 |
FQ3 2026 (Sep 2026) | 0.02B | -- | 0.02B | 0.02B | 0 |
FQ2 2026 (Jun 2026) | 0.03B | 5.17 | 0.02B | 0.03B | 0 |
FQ1 2026 (Mar 2026) | 0.02B | 25.72 | 0.02B | 0.02B | 0 |
FQ4 2025 (Oct 2025) | 0.02B | -8.2 | 0.02B | 0.02B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.05 | 0.87 | 0.92 | 105.75% |
FQ1 2025 (Mar 2025) | -0.06 | -0.52 | -0.46 | 88.46% |
FQ4 2024 (Dec 2024) | -0.035 | 0 | 0.035 | INF% |
FQ3 2024 (Sep 2024) | -0.055 | -1.1 | -1.045 | 95% |
FQ2 2024 (Jun 2024) | 1.34259 | -1.34 | -2.68259 | 200.19% |
FQ1 2024 (Mar 2024) | -0.17 | -0.17 | 100% | |
FQ4 2023 (Dec 2023) | 0.0789 | 0.0789 | 100% | |
FQ3 2023 (Sep 2023) | -0.2 | -0.2 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0.01B | $0.02B | $10.01M | 42.21% |
FQ1 2025 (Mar 2025) | $0.01B | $0.01B | $0.42M | 3.28% |
FQ4 2024 (Dec 2024) | $0.01B | $0.02B | $3.2M | 18.69% |
FQ3 2024 (Sep 2024) | $0.01B | $0.01B | $1.16M | 8.51% |
FQ2 2024 (Jun 2024) | $0.02B | $0.01B | $-4.3M | -31.91% |
FQ1 2024 (Mar 2024) | $0B | $0.01B | $9.12M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.01B | $14.11M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.01B | $10.44M | 100% |